BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26489663)

  • 1. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
    Trevithick L; McAllister-Williams RH; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Ellwell C; Hayden K; Holland F; Karim S; Lowe J; Loo C; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; Anderson IM
    BMC Psychiatry; 2015 Oct; 15():257. PubMed ID: 26489663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
    Anderson IM; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Elwell C; Hayden K; Holland F; Karim S; Loo C; Lowe J; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; McAllister-Williams RH;
    Lancet Psychiatry; 2017 May; 4(5):365-377. PubMed ID: 28359862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Low Dose of Ketamine on Learning Memory Function in Patients Undergoing Electroconvulsive Therapy-A Randomized, Double-Blind, Controlled Clinical Study.
    Chen Q; Min S; Hao X; Peng L; Meng H; Luo Q; Chen J; Li X
    J ECT; 2017 Jun; 33(2):89-95. PubMed ID: 27828927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial.
    Loo CK; Katalinic N; Garfield JB; Sainsbury K; Hadzi-Pavlovic D; Mac-Pherson R
    J Affect Disord; 2012 Dec; 142(1-3):233-40. PubMed ID: 22858219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.
    Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X
    J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function after electroconvulsive therapy for depression: relationship to clinical response.
    Anderson IM; McAllister-Williams RH; Downey D; Elliott R; Loo C
    Psychol Med; 2021 Jul; 51(10):1647-1656. PubMed ID: 32102725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study.
    Spaans HP; Verwijk E; Comijs HC; Kok RM; Sienaert P; Bouckaert F; Fannes K; Vandepoel K; Scherder EJ; Stek ML; Kho KH
    J Clin Psychiatry; 2013 Nov; 74(11):e1029-36. PubMed ID: 24330903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial.
    Fernie G; Currie J; Perrin JS; Stewart CA; Anderson V; Bennett DM; Hay S; Reid IC
    Br J Psychiatry; 2017 Jun; 210(6):422-428. PubMed ID: 28254962
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
    Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
    Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
    Anand A; Mathew SJ; Sanacora G; Murrough JW; Goes FS; Altinay M; Aloysi AS; Asghar-Ali AA; Barnett BS; Chang LC; Collins KA; Costi S; Iqbal S; Jha MK; Krishnan K; Malone DA; Nikayin S; Nissen SE; Ostroff RB; Reti IM; Wilkinson ST; Wolski K; Hu B
    N Engl J Med; 2023 Jun; 388(25):2315-2325. PubMed ID: 37224232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.
    Jha MK; Wilkinson ST; Krishnan K; Collins KA; Sanacora G; Murrough J; Goes F; Altinay M; Aloysi A; Asghar-Ali A; Barnett B; Chang L; Costi S; Malone D; Nikayin S; Nissen SE; Ostroff R; Reti I; Wolski K; Wang D; Hu B; Mathew SJ; Anand A
    JAMA Netw Open; 2024 Jun; 7(6):e2417786. PubMed ID: 38916891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression.
    Rybakowski JK; Bodnar A; Krzywotulski M; Chlopocka-Wozniak M; Michalak M; Rosada-Kurasinska J; Bartkowska-Sniatkowska A
    J ECT; 2016 Sep; 32(3):164-8. PubMed ID: 27008330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive training to improve memory in individuals undergoing electroconvulsive therapy: Negative findings.
    Choi J; Wang Y; Feng T; Prudic J
    J Psychiatr Res; 2017 Sep; 92():8-14. PubMed ID: 28376409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials.
    Zheng W; Li XH; Zhu XM; Cai DB; Yang XH; Ungvari GS; Ng CH; Ning YP; Hu YD; He SH; Wang G; Xiang YT
    J Affect Disord; 2019 May; 250():123-131. PubMed ID: 30852364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine and other glutamate receptor modulators for depression in adults.
    Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate and long-term effects of bilateral electroconvulsive therapy on cognitive functioning in patients with a depressive disorder.
    Nuninga JO; Claessens TFI; Somers M; Mandl R; Nieuwdorp W; Boks MP; Bakker S; Begemann MJH; Heringa S; Sommer IEC
    J Affect Disord; 2018 Oct; 238():659-665. PubMed ID: 29966930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study.
    Yoosefi A; Sepehri AS; Kargar M; Akhondzadeh S; Sadeghi M; Rafei A; Alimadadi A; Ghaeli P
    J ECT; 2014 Mar; 30(1):15-21. PubMed ID: 24091902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Performance Under Electroconvulsive Therapy (ECT) in ECT-Naive Treatment-Resistant Patients With Major Depressive Disorder.
    Ziegelmayer C; Hajak G; Bauer A; Held M; Rupprecht R; Trapp W
    J ECT; 2017 Jun; 33(2):104-110. PubMed ID: 28169947
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.